NZ217400A - Recombinant virus optimised to increase immunogenicity of expressed foreign peptides; dna molecule and peptide - Google Patents
Recombinant virus optimised to increase immunogenicity of expressed foreign peptides; dna molecule and peptideInfo
- Publication number
- NZ217400A NZ217400A NZ217400A NZ21740086A NZ217400A NZ 217400 A NZ217400 A NZ 217400A NZ 217400 A NZ217400 A NZ 217400A NZ 21740086 A NZ21740086 A NZ 21740086A NZ 217400 A NZ217400 A NZ 217400A
- Authority
- NZ
- New Zealand
- Prior art keywords
- optimised
- peptide
- dna molecule
- recombinant virus
- increase immunogenicity
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title 2
- 108020004414 DNA Proteins 0.000 title 1
- 102000053602 DNA Human genes 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 230000005847 immunogenicity Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPH219885 | 1985-08-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ217400A true NZ217400A (en) | 1989-09-27 |
Family
ID=3771250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ217400A NZ217400A (en) | 1985-08-29 | 1986-08-29 | Recombinant virus optimised to increase immunogenicity of expressed foreign peptides; dna molecule and peptide |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0244427A4 (en) |
| JP (1) | JPS63500637A (en) |
| KR (1) | KR880700073A (en) |
| AU (1) | AU594087B2 (en) |
| DK (1) | DK219187D0 (en) |
| ES (1) | ES2002128A6 (en) |
| FI (1) | FI871885A (en) |
| IL (1) | IL79880A0 (en) |
| NZ (1) | NZ217400A (en) |
| WO (1) | WO1987001386A1 (en) |
| ZA (1) | ZA866582B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5182211A (en) * | 1987-08-07 | 1993-01-26 | Institut Pasteur | Plasmid vectors encoding a protein of a picornavirus |
| EP0398944A4 (en) * | 1988-02-05 | 1991-09-11 | Commonwealth Scientific And Industrial Research Organisation | Gene expression system (particularly for rotavirus vp7 protein) involving a foreign signal peptide and optionally a transmembrane anchor sequence |
| FR2663228A2 (en) * | 1989-09-29 | 1991-12-20 | Agronomique Inst Nat Rech | Immunising composition against Newcastle disease and method of preparation |
| US8101189B2 (en) | 2002-07-05 | 2012-01-24 | Folia Biotech Inc. | Vaccines and immunopotentiating compositions and methods for making and using them |
| CN1665528B (en) | 2002-07-05 | 2013-05-15 | 弗利亚生物技术公司 | Adjuvant viral particle |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2442271A1 (en) * | 1978-11-27 | 1980-06-20 | Pasteur Institut | VECTOR FOR THE INSERTION OF A PROKARYOTE OR EUKARYOTE GENE, AND EXCRETION OF THE EXPRESSED PROTEIN |
| US4603112A (en) * | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
| US4593002A (en) * | 1982-01-11 | 1986-06-03 | Salk Institute Biotechnology/Industrial Associates, Inc. | Viruses with recombinant surface proteins |
| WO1984002077A1 (en) * | 1982-11-30 | 1984-06-07 | Us Health | Process for producing poxvirus recombinants for expression of foreign genes |
| AU569722B2 (en) * | 1983-01-28 | 1988-02-18 | Saramane Pty Ltd | Expression of plasmodium falciparum polypeptides from cloned cdna |
| EP0162738A1 (en) * | 1984-04-09 | 1985-11-27 | MOLECULAR GENETICS RESEARCH & DEVELOPMENT LIMITED PARTNERSHIP | Production of pseudorabies virus subunit vaccines |
| FR2563434B1 (en) * | 1984-04-25 | 1986-07-25 | Transgene Sa | Rabies vaccine and process for its preparation |
-
1986
- 1986-08-28 IL IL79880A patent/IL79880A0/en unknown
- 1986-08-29 AU AU63701/86A patent/AU594087B2/en not_active Ceased
- 1986-08-29 NZ NZ217400A patent/NZ217400A/en unknown
- 1986-08-29 EP EP19860905164 patent/EP0244427A4/en not_active Withdrawn
- 1986-08-29 ES ES8601549A patent/ES2002128A6/en not_active Expired
- 1986-08-29 WO PCT/AU1986/000256 patent/WO1987001386A1/en not_active Application Discontinuation
- 1986-08-29 ZA ZA866582A patent/ZA866582B/en unknown
- 1986-08-29 JP JP61505157A patent/JPS63500637A/en active Pending
-
1987
- 1987-04-20 KR KR1019870700378A patent/KR880700073A/en not_active Application Discontinuation
- 1987-04-29 FI FI871885A patent/FI871885A/en not_active IP Right Cessation
- 1987-04-29 DK DK219187A patent/DK219187D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0244427A1 (en) | 1987-11-11 |
| AU6370186A (en) | 1987-03-24 |
| DK219187A (en) | 1987-04-29 |
| EP0244427A4 (en) | 1989-04-27 |
| FI871885A0 (en) | 1987-04-29 |
| ES2002128A6 (en) | 1988-07-16 |
| DK219187D0 (en) | 1987-04-29 |
| IL79880A0 (en) | 1986-11-30 |
| FI871885A (en) | 1987-04-29 |
| KR880700073A (en) | 1988-02-15 |
| JPS63500637A (en) | 1988-03-10 |
| AU594087B2 (en) | 1990-03-01 |
| WO1987001386A1 (en) | 1987-03-12 |
| ZA866582B (en) | 1987-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1353295A (en) | Peptides derived from a retrovirus of the HIV group, and their use | |
| NZ212155A (en) | Purification of protein/peptide material by electroseparation | |
| ZA861482B (en) | Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known | |
| EP0531080A3 (en) | Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene protein | |
| AU6698786A (en) | Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses | |
| NZ217400A (en) | Recombinant virus optimised to increase immunogenicity of expressed foreign peptides; dna molecule and peptide | |
| HUT44622A (en) | New antigen-active proteins and peptides and feline peritonitis virus vaccine (fipv) | |
| GB2171703B (en) | Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re | |
| NZ236357A (en) | Vaccine and polypeptide containing immunogenic determinant from flanking region of plasmodium surface protein | |
| FR2726576B1 (en) | PRODUCTION OF HYDROPHOBIC PEPTIDE-LIKE PEPTIDES, RECOMBINANT PEPTIDE, CORRESPONDING DNA SEQUENCE | |
| DK262986A (en) | PEPTID MATERIAL WITH THYMUS HUMORAL ACTIVITY | |
| EP0412762A3 (en) | Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene proteins | |
| NZ219192A (en) | Peptides related to p97 melanoma-associated peptide, recombinant virus and vaccines | |
| EP0503950A3 (en) | Method of purifying recombinant hepatitis b virus surface proteins from recombinant cells | |
| EP0226800A3 (en) | Novel recombinant gene and use thereof | |
| NZ224393A (en) | Recombinant hiv envelope proteins and uses thereof | |
| EP0276330A4 (en) | Recombinant plasmid dnas, coding for synthesis of polypeptide substances for a vaccine against hepatitis a. | |
| AU571460B2 (en) | Alpha interferon dna, recombinant plasmid, engineered organism and alpha interferon polypeptide | |
| HUT43110A (en) | New antigene-active proteines and peptides and infective bronchitis virus /ibv/ vaccines | |
| IL92119A0 (en) | Purification of green-plant phytochrome protein and cloning of greenphytochrome genes | |
| AU2913189A (en) | Peptide corresponding to hiv-env 583-599, and analogs thereof and applications of the peptides | |
| GB8828726D0 (en) | Purification of recombinant protein | |
| HU900212D0 (en) | Process for ensymatical preparation of proteins and peptides not giving rise to food-allergy | |
| IE893442L (en) | Recombinant dna sequence capable of expressing bovine¹trophablast protein | |
| IL81246A0 (en) | Labelling of peptides and proteins |